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Abstract
 To investigate the participation rates in gastric, liver, colorectal, breast, and cervical cancer screening 
in Korea, including both organised and opportunistic programmes, a nationwide interview survey using 
multi-stage random sampling was conducted in 2010. A total of 4,056 cancer-free men aged over 40 years 
and women aged 30 years participated. Lifetime screening rates ranged from 54.2% (liver cancer) to 79.5% 
(breast cancer) and rates of screening in accordance with guidelines ranged from 22.9% (liver cancer) to 
65.1% (gastric cancer). Upper endoscopy was the preferred method for gastric cancer, whereas the faecal 
occult blood test was conducted most often for colorectal cancer. The main reason stated for non attendance 
was ‘no symptoms.’ To increase attendance at cancer-screening programmes, efforts to increase education 
and accessibility of screening programmes are necessary.  
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Introduction
 In 2008, it was estimated that nearly 12.7 million new 
cancer cases were diagnosed worldwide and 7.6 million 
people died of cancer. However, a striking geographic 
variation characterises the incidence of cancer, with the 
highest in North America (3.7 million) and the lowest 
in Micronesia/Polynesia (1800; International Agency 
for Research on Cancer, 2011). In Korea, 179,000 new 
cancer cases and 70,000 cancer deaths occur annually 
(Jung et al., 2011), and Korea has among the highest 
cancer rates in the world (International Agency for 
Research on Cancer, 2011). The cancer incidence in 
Korea has been increasing by 3.3% per year and cancer 
is now the most common cause of death, although the 
5-year survival rate for cancer has also increased, from 
41.2% in 1993–1995 to 59.5% in 2004–2008 (Jung et 
al., 2011).
 To reduce the disease burden, cancer screening 
programmes have been provided in Korea, and in 1999 
the government started the National Cancer Screening 
Programme (NCSP). The NCSP provides free screening 
services for gastric, liver, colorectal, breast, and 
cervical cancers to Medicaid beneficiaries and people 
with National Health Insurance, a mandatory medical 
insurance system for those within the lower 50% income 
bracket (Yoo, 2008). People in the higher 50% income 
bracket can also be screened for these five cancers and 
90% of the cost is subsidised. The NCSP guidelines are 
presented in Table 1. Being screened in accordance with 
the recommended guidelines is important for detecting 
cancer at an early stage and in reducing mortality through 
treatment (Senore et al., 2010).
 In addition to these organised screening programmes, 
opportunistic screening is widely available in Korea. 
Opportunistic screening programmes involve various 
options in terms of the items screened, intervals 
between screening, and costs, depending on individual 
preferences, but these services are paid for entirely by 
the users. Although screening programmes are conducted 
widely in Korea, the utilisation of these screening 
programmes, including both organised and opportunistic 
programmes, is unclear.
 Thus, in this study, we investigated the utilisation of 
the five kinds of cancer-screening programmes included 
in the NCSP, in both organised and opportunistic 
programmes.
Materials and Methods
Study population and data
 Cancer-free men older than 40 years and women older 
than 30 years were the target population. This study used 
data from the 2010 Korean National Cancer Screening 
Survey (KNCSS), which is a population-based, 
nationwide, cross-sectional interview survey that has 
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was applied. First, we stratified the sample according to 
geographic area, age, and sex. We designated the number 
of enumeration districts in proportion to their size and 
selected the final study areas randomly. Five to eight 
households were randomly chosen in each urban area 
and 10–12 households were randomly chosen in each 
rural area, and one eligible person in each household 
was selected as a participant. Face-to-face interviews by 
door-to-door contact were used for study recruitment.
The 2010 KNCSS was conducted from October 10 to 
November 12, 2010, and we sampled and contacted 
11,742 people. Of these, 7,613 refused to participate 
(64.8%), 47 (0.4%) did not complete the interview, and 
4,082 completed interviews (34.8%).
 We used a structured questionnaire to collect 
information on sociodemographic characteristics, life-
time screening experience, knowledge and experience 
of screening methods, interval between screenings, and 
reasons for non-attendance. Of those interviewed, 26 
participants were missing key information, so 4,056 were 
ultimately analysed.
Statistical analyses 
 Lifetime screening rates were calculated by using the 
number of subjects within the target age range for each 
screening method as the denominator and the number 
of subjects examined as the numerator. The screening 
rate according to guidelines was calculated by using 
the number of subjects within the target age for each 
screening method as the denominator and the number of 
subjects examined in accordance with guidelines as the 
numerator (Table 1). The proportion of non-attendance 
was calculated based on the number who had never been 
examined.
Results 
 Table 2 shows the characteristics of the participants, 
such as age group, residential area, marital status, 
education, income, medical insurance, and private 
medical insurance, by sex. 
 The lifetime screening rates were 76.7% for gastric 
cancer, 54.2% for liver cancer, 57.1% for colorectal 
cancer, 79.5% for breast cancer, and 75.0% for cervical 
cancer. The rates for screening in accordance with 
guidelines for gastric, liver, colorectal, breast, and 
cervical cancer were 65.1%, 22.9%, 33.5%, 61.1%, and 
62.9%, respectively (Table 3). Of the subjects, 33.0% 
underwent an upper gastrointestinal series (UGI) and 
70.6% underwent endoscopies; 58.9% of the participants 
followed the recommended interval for UGI, as did 
58.9% of those who underwent endoscopies. The faecal 
occult blood test (FOBT) was performed in 46.3%, a 
colonoscopy in 34.9%, and a double-contrast barium 
enema (DCBE) in 10.4%. Adherence to the guidelines 
was highest in the order DCBE (25.9%) > colonoscopy 
(23.3%) > FOBT (6.1%).
 The screening rates in accordance with guidelines 
Table 1. Cancer Screening Guidelines Issued by the 
National Cancer Screening Programme (NCSP) in 
Korea   
Cancer Target population Interval Test
Stomach Age 40 and over 2 years Upper   
                    endoscopy   
   or UGI 1
Liver High-risk group2 6 months   Ultrasonography  
 aged 40 and over                   and AFP
Colorectal Age 50 and over 1 year FOBT 3
Breast Age 40 and over,  2 years Mammography
 women
Cervix Age 30 and over,  2 years Pap smear
  women
UGI, upper gastrointestinal series; AFP, alpha-fetoprotein; 
DCBE, double contrast barium enema; FOBT; faecal occult 
blood test; 1In the case of an abnormality on the UGI, 
endoscopy is recommended and a biopsy is performed when 
an abnormality is found at endoscopy; 2Those at high risk for 
liver cancer include patients with chronic hepatitis determined 
from serological evidence of infection with hepatitis B or C 
virus in liver cirrhosis; 3In the case of an abnormality on the 
FOBT, colonoscopy or a double-contrast barium enema is 
recommended and a biopsy is performed when an abnormality 
is found at colonoscopy.   
Table 2. Baseline Characteristics of Study Participants   
Variables    Male (n= 1681) Female (n= 2375) Total (n= 4056)
      n (%)          n (%)           N (%)
Age (years)   
 30–39 -1 643 (27.1) 643 (15.9)
 40–49 725 (43.1) 689 (29.0) 1414 (34.9)
 50–59 556 (33.1) 552 (23.2) 1108 (27.3)
 60–69 320 (19.0) 362 (15.2) 682 (16.8)
 70–74 80 (4.8) 129 (5.4) 209 (5.2)
Residence   
 Metropolitan 732 (43.6) 1065 (44.8) 1797 (44.3)
 Urban 730 (43.4) 981 (41.3) 1711 (42.2)
 Rural 219 (13.0) 329 (13.9) 548 (13.5)
 Marital status   
 Without spouse 74 (4.4) 271 (11.4) 345 (8.5)
 With spouse 1607 (95.6) 2104 (88.6) 3711 (91.5)
Education (years)   
 ≤11 248 (14.8) 526 (22.2) 774 (19.1)
 12–14 853 (50.7) 1259 (53.0) 2112 (52.1)
 15≤ 580 (34.5) 590 (24.8) 1170 (28.9)
Monthly household income (US dollars) 2  
 ≤2,499  506 (30.1) 730 (30.8) 1237 (30.5)
 2,500–3,999  634 (37.7) 934 (39.3) 1568 (38.7)
 >4,000 540 (32.1) 709 (29.9) 1249 (30.8)
Medical insurance    
 National Health 1638 (97.4) 2278 (95.9) 3916 (96.6)
 Insurance
 Medical Aid 43 (2.6) 97 (4.1) 140 (3.5)
 Programme
Private medical insurance   
 No 366 (21.8) 404 (17.0) 770 (19.0)
 Yes 1315 (78.3) 1971 (83.0) 3286 (81.0)
1The criteria for eligibility were men older than 40 years and 
women older than 30 years;21 US dollar = 1,000 won  
been conducted annually by the Korean National Cancer 
Centre since 2004, and multi-stage random sampling 
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according to age, education, and income level are 
presented in Figure 1. The rates of adherence to the 
guidelines for gastric and liver cancer screening increased 
until age 60–69 years and then decreased in the 70–74 age 
group, whereas rates of adherence to the guidelines for 
breast and cervical cancer screening increased until the 
50s and then decreased significantly. The screening rates 
in accordance with guidelines for gastric and cervical 
cancer screening differed according to education and 
income, but the difference was minimal for gastric cancer 
screening.
 Table 4 shows the stated reason for lifetime non-
attendance at screening for each cancer type. Across 
all cancer types, the reason most often stated was 
“no symptoms,” which accounted for more than 40% 
of gastric, colorectal, and cervical cancer screening, 
and then “lack of time.” For gastric and breast cancer 
screening, the third most common reason for non-
attendance was “economic reasons,” whereas “fear of the 
exam procedure” was stated as the third most common 
reason in regard to liver, colorectal, and cervical cancer 
screening.
Discussion
Although the use of organised cancer-screening 
programmes is well understood and attendance rates 
have been increasing rapidly (Choi et al., 2010; Lee 
et al., 2010; Lim et al., 2010), the use of opportunistic 
programmes is unclear. The NCSP has been expanded 
since it started in 1999 and more than 50% of the 
population is now targeted, although only 31.7% of the 
target population participate in the programme. Most 
of the costs of opportunistic programmes are covered 
entirely by users, yet the percentage attending has been 
increasing rapidly because satisfaction with the screening 
procedures and with the reliability of the results is high in 
terms of sufficient education, follow-up, diagnostic tools 
and treatment, and rapid test results (Shin et al., 2006). 
This is reflected by the fact that more than 80% of the 
participants in this study had private medical insurance 
in addition to the National Health Insurance and Medical 
Aid Programme, which covered all participants.
As a result of government efforts to increase cancer-
screening rates, the lifetime screening rates ranged 
between 54.2% and 79.5% and screening rates based 
on the guidelines ranged between 22.9% and 65.1%. 
Several screening options exist for gastric and colorectal 
cancer, such as an UGI and endoscopy for gastric cancer; 
and FBOT, colonoscopy, and DCBE for colorectal 
cancer; other cancer-screening programmes emphasise 
a single test. Although one study suggested that the 
relative complexity of screening was one reason for the 
low screening rates (Han et al., 2010), gastric cancer 
screening had both a high lifetime screening rate, similar 
to those for breast cancer and cervical cancer screening 
(>75.0%) and a higher screening rate in accordance with 
guidelines (>60.0%). 
Overall, the rate of endoscopy testing was higher than 
that of upper GI series testing. The results are similar 
Table 3. Participation Rates in the 2010 National 
Cancer Screening Programme in, Korea    
Type of cancer     Screening tool        Lifetime Screening  
             screening  in accordance
                                 rate      with
                                    guidelines
Gastric cancer1 Total6 76.70% 65.10%
 UGI  33.00% 24.90%
 Upper endoscopy 70.60% 58.90%
Liver cancer2 US and AFP 54.20% 22.90%
Colorectal cancer3 Total6 57.10% 35.50%
 FOBT 46.30% 25.90%
 Colonoscopy 34.90% 23.30%
 DCBE  10.40% 6.10%
Breast cancer4 Mammography 79.50% 61.10%
Cervical cancer5 Pap smear 75.00% 62.90%
UGI, upper gastrointestinal series; US, ultrasonography; AFP, 
alpha-fetoprotein; DCBE, double-contrast barium enema; 
FOBT; faecal occult blood test;1For those older than 40 years, 
upper gastrointestinal series or endoscopy every 2 years;2For 
those older than 40 years and diagnosed with liver cirrhosis 
or hepatitis B antigen or C antibody carrier, ultrasonography 
and serum alpha-fetoprotein every 6 months;3For those 
older than 50 years, faecal occult blood test every year, 
colonoscopy every 10 years, double-contrast barium enema 
every 5 years;4For those older than 40 years, mammogram 
every 2 years;5For those older than 30 years, Pap smear 
every 2 years;6The counts can overlap because some of the 
participants underwent more than two examinations  
Table 4. The Distribution of the Reasons Stated for Lifetime Non-attendance at Screening     
Cause of  Gastric cancer Liver cancer 1 Colorectal cancer Breast cancer  Cervical cancer 
non-attendance               (n = 796)  (n = 38)  (n = 857)  (N = 356) (N = 593)
 n (%) n (%) N (%) N (%) N (%)
No symptoms 394 (49.5) 14 (36.8) 412 (48.1) 141 (39.6) 247 (41.7)
Lack of time 202 (25.4) 10 (26.3) 164 (19.1) 87 (24.4) 146 (24.6)
Economic reasons 79 (9.9) 3 (7.9) 102 (11.9) 55 (15.5) 58 (9.8)
Fear of exam procedure 67 (8.4) 4 (10.5) 133 (15.5) 36 (10.1) 82 (13.8)
Fear of detecting cancer 37 (4.7) 4 (10.5) 30 (3.5) 22 (6.2) 37 (6.2)
Ignorance about screening 9 (1.1) 4 (10.5) 5 (0.6) 5 (1.4) 11 (1.9)
Distrust screening 7 (0.9) 2 (5.3) 10 (1.2) 10 (2.8) 8 (1.4)
Other 1 (0.1) 1 (2.6) 1 (0.1) 0 (0.0) 4 (0.7)
1Screening tests are recommended for the high-risk group, defined as those older than 40 years and diagnosed with liver 
cirrhosis or hepatitis B antigen or C antibody carrier    
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other types of cancer screening. In colorectal cancer 
screening, the lifetime FOBT rate was higher than that 
for colonoscopy or DCBE. Moreover, the number of 
subjects undergoing FOBT for colorectal screening 
has been increasing, whereas the number undergoing 
colonoscopy has not changed, although the total rate of 
colorectal screening has increased (Choi et al., 2010). 
In contrast, in the USA, the rate of colorectal screening 
using sigmoidoscopy or colonoscopy is much higher 
than that of FOBT, and screening using endoscopy has 
increased but use of FOBT has decreased (Smith et al., 
2008).
Liver cancer screening is recommended for patients 
with liver cirrhosis, chronic hepatitis due to hepatitis B 
virus (HBV) or hepatitis C virus (HCV), or serological 
evidence of HBV or HCV infection. Although these 
are high-risk groups for liver cancer compared with the 
normal population, the lifetime screening rate and the rate 
in accordance with guidelines was the lowest among the 
five types of cancer. A study conducted in Korea indicated 
that less than 60% of HBV or HCV carriers had ever been 
tested using ultrasonography, and of those who had been 
examined by ultrasonography, less than 30% had been 
tested within the previous year, although they knew their 
carrier status (Cho et al., 2010).
According to age, the rates of screening in accordance 
with guidelines for gastric and colorectal cancer 
screening increased until the 60s and then decreased, 
whereas those for breast and cervical cancer screening 
increased until the 50s and then decreased. Although 
controversy as to whether socioeconomic status is 
associated with screening rates exists (Richardson et 
al., 1990; Cho et al., 2004; Zackrisson et al., 2004; Han 
et al., 2010), the differences were less than 6%, except 
in the case of cervical cancer, in our results. Kwak et al. 
(Kwak et al., 2005) also reported that in Korea income 
was associated with screening rates only in the case of 
cervical cancer.
The main reason given for non-attendance for all five 
kinds of cancer screening was no symptoms. This is a 
common reason in both developing (Basu et al., 2006) 
and developed (Matthews et al., 2007) countries. In one 
study, the presence of symptoms was the main reason 
for undergoing a screening test (Puschel et al., 2010). 
Because the goal of screening is early detection of disease 
at a preclinical or early clinical stage in order to reduce 
morbidity and mortality, education is needed to increase 
participation rates in screening programmes. The second 
reason given for non-attendance was a lack of time, and 
the third and fourth reasons were economic reasons and 
fear of the examination procedure, respectively. Thus, 
efforts to increase the accessibility of screening tests in 
diverse ways should be combined with education about 
the importance of screening tests.
This study conducted a nationwide survey to 
investigate participation rates in cancer screening for five 
kinds of cancers in Korea and reported the current status. 
However, this study has several limitations. First, our 
 (b) Education 
(c) Monthly household income (US dollars) 1
Figure 1. Screening Rate with Recommendation 
According to Age, Education and Income. 11 US 
dollar=1,000 won
to those of a previous population study in Korea (Choi 
et al., 2009).  It may be that upper endoscopy is widely 
applied because it not only screens for gastric cancer, 
at almost the same cost as an upper GI series, but also 
allows diagnosis of gastric ulcer and Helicobacter pylori 
infection (Kim et al., 2009), thus affecting the preference 
for endoscopy (Choi et al., 2009).
The breast cancer screening rate is higher in the 
United States of America (USA), whereas the cervical 
cancer screening rate is lower (Smith et al.). The breast 
cancer screening rate has been increasing rapidly in 
Korea (Lim et al., 2010; Choi et al., 2010) and the 
cervical cancer screening rate has also been increasing, 
but less rapidly. The incidence of breast cancer has been 
increasing rapidly, whereas that of cervical cancer has 
been decreasing (Jung et al., 2011), and these patterns 
may be responsible for the more rapid increase in breast 
cancer screening.
The screening rate and the screening rate in 
accordance with guidelines were lower for liver and 
colorectal cancer screening than was the case for 
 (a) Age (years) 
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results relied on self-reported data. Some tests may have 
been performed following a physician’s order for other 
purposes because screening tools such as endoscopies 
are used not only for cancer but also for the diagnosis 
and follow-up of other diseases. Although the survey 
data from self-reported interview may have introduced 
a bias, many studies have shown the reliability of self-
reported histories of cancer screening, which have been 
shown to agree well with medical records (Caplan et 
al., 2003; Hoffmeister et al., 2007; Jones et al., 2008). 
Second, the response rate in our study was only about 
35%, which may have distorted our sample. However, 
compared with other nationwide studies conducted in 
Korea (Jeong et al., 2007; Kwon et al., 2009; Park et 
al., 2008), our response rate is considered acceptable in 
the Korean context.  
The Korean government instituted a national health-
promotion programme for cancer control that includes 
strategies such as strengthening cancer prevention by 
managing cancer risk factors, achieving early cancer 
screening among all Koreans by improving medical 
coverage and expanding support for cancer patients, 
strengthening support for rehabilitation and palliative 
care for cancer patients, building an infrastructure for 
active national cancer control, developing world-class 
medical treatments and techniques, educating and 
advertising to improve our understanding of cancer, 
and registering cancer patients and evaluating their 
care systematically. One of the goals is to achieve a 
cancer screening rate with related recommendations for 
70% of the Korean population by the year 2015 (Han 
et al., 2011). According to our results, screening rates 
for gastric, breast, and cervical cancer are approaching 
this goal (>60%), but greater effort is still needed to 
increase screening rates and recommendations for liver 
and colorectal cancer. 
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